SPY453.42-3.98 -0.87%
DIA346.24-0.37 -0.11%
IXIC15,085.47-295.85 -1.92%

Oncorus Signs Licensing Agreement with Gaeta Therapeutics for Use of Interleukin-12 in Combination With Immunotherapies for Cancer Treatment

MT Newswires · 11/11/2021 03:12

Please log in to view news